Kieran Ryan
Stock Analyst at Deutsche Bank
(1.89)
# 3,331
Out of 5,058 analysts
5
Total ratings
50%
Success rate
3.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kieran Ryan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Reiterated: Buy | $190 → $180 | $141.10 | +27.57% | 2 | Aug 6, 2026 | |
| DXCM DexCom | Rated: Buy | $86 → $92 | $86.04 | +6.93% | 2 | Jul 31, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Hold | $16 | $16.24 | -4.56% | 1 | Jun 23, 2026 |
Insulet
Aug 6, 2026
Reiterated: Buy
Price Target: $190 → $180
Current: $141.10
Upside: +27.57%
DexCom
Jul 31, 2026
Rated: Buy
Price Target: $86 → $92
Current: $86.04
Upside: +6.93%
Tandem Diabetes Care
Jun 23, 2026
Initiated Coverage: Hold
Price Target: $16
Current: $16.24
Upside: -4.56%